Citigroup Inc. Purchases 110,012 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Citigroup Inc. raised its position in Option Care Health, Inc. (NASDAQ:OPCH) by 27.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 516,680 shares of the company’s stock after buying an additional 110,012 shares during the quarter. Citigroup Inc.’s holdings in Option Care Health were worth $16,172,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in OPCH. UMB Bank n.a. grew its stake in shares of Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after acquiring an additional 750 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after purchasing an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. grew its position in shares of Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after purchasing an additional 1,446 shares in the last quarter. Blue Trust Inc. increased its holdings in shares of Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares during the period. Finally, International Assets Investment Management LLC raised its position in shares of Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after buying an additional 2,757 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on OPCH. The Goldman Sachs Group lowered Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Truist Financial dropped their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Finally, JMP Securities upped their price target on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $30.83.

Option Care Health Trading Up 0.1 %

OPCH opened at $23.76 on Thursday. The company has a market cap of $4.04 billion, a P/E ratio of 19.97, a PEG ratio of 2.42 and a beta of 1.32. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company’s 50 day moving average is $27.16 and its 200-day moving average is $28.96. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.63.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the stock in a transaction on Friday, November 8th. The stock was acquired at an average price of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.64% of the stock is owned by insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.